Publications by authors named "A Y Filatova"

The development of optical sensors for label-free quantification of cell parameters has numerous uses in the biomedical arena. However, using current optical probes requires the laborious collection of sufficiently large datasets that can be used to calibrate optical probe signals to true metabolite concentrations. Further, most practitioners find it difficult to confidently adapt black box chemometric models that are difficult to troubleshoot in high-stakes applications such as biopharmaceutical manufacturing.

View Article and Find Full Text PDF

Context: Pathogenic variants in the TBCE gene, encoding tubulin-specific chaperone E crucial for tubulin folding, are linked to three severe neurodevelopmental disorders: Hypoparathyroidism-retardation-dysmorphism (HRD) syndrome, Kenny-Caffey syndrome type 1, and progressive encephalopathy with amyotrophy and optic atrophy.

Objective: We identified patients with a novel, milder TBCE-associated phenotype and aimed to characterize it at the clinical and molecular levels.

Materials And Methods: We conducted splicing analysis using deep NGS sequencing of RT-PCR products and detected TBCE through Western blotting.

View Article and Find Full Text PDF
Article Synopsis
  • * Affected individuals typically experience more severe heart failure symptoms and poorer outcomes, influencing treatment choices based on how severe the dysfunction is.
  • * Echocardiography is a key tool for evaluating left atrial function, and analyzing strain parameters can help identify early issues and guide prognosis and treatment strategies in HFpEF.
View Article and Find Full Text PDF
Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) is a rare, autosomal recessive disorder with 11 genetic subtypes linked to dysfunction in specific protein complexes, leading to symptoms like albinism, bleeding disorders, and visual impairments.
  • A study examined 11 patients from eight families with albinism, discovering both novel and previously identified genetic variants related to HPS1, HPS6, and HPS9.
  • To devise effective treatment and follow-up strategies, a comprehensive understanding of the disease's clinical and genetic diversity is crucial, often requiring interdisciplinary methods and advanced diagnostic techniques like RNA analysis.
View Article and Find Full Text PDF

Multiple osteochondromas (MO) is a rare autosomal dominant skeletal disorder characterized by the development of multiple benign tumors known as osteochondromas. The condition is predominantly caused by loss-of-function variants in the or genes, facilitating relatively precise clinical diagnosis through established diagnostic criteria. Despite this, a notable percentage of MO cases (10%-20%) remains unresolved after sequencing coding regions and copy number analysis of both genes.

View Article and Find Full Text PDF